Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer.

NCT06497777 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06497777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer.
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 6, 2024
Completion date
June 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microrna, pancreas adenocarcinoma